These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 29993162)
1. Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: Japan-Great Outcome of Long-term trial with Donepezil (J-GOLD). Arai H; Hashimoto N; Sumitomo K; Takase T; Ishii M Psychogeriatrics; 2018 Sep; 18(5):402-411. PubMed ID: 29993162 [TBL] [Abstract][Full Text] [Related]
2. Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: interim results from the long-term, large-scale J-GOLD study in Japan. Arai H; Sumitomo K; Sakata Y; Daidoji K; Takase T; Toyoda T Psychogeriatrics; 2016 Mar; 16(2):107-15. PubMed ID: 26114729 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
4. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation. Kudoh C; Arita R; Honda M; Kishi T; Komatsu Y; Asou H; Mimura M Psychogeriatrics; 2016 Mar; 16(2):85-92. PubMed ID: 25918972 [TBL] [Abstract][Full Text] [Related]
5. 3-year study of donepezil therapy in Alzheimer's disease: effects of early and continuous therapy. Winblad B; Wimo A; Engedal K; Soininen H; Verhey F; Waldemar G; Wetterholm AL; Haglund A; Zhang R; Schindler R Dement Geriatr Cogn Disord; 2006; 21(5-6):353-63. PubMed ID: 16508298 [TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Homma A; Takeda M; Imai Y; Udaka F; Hasegawa K; Kameyama M; Nishimura T Dement Geriatr Cogn Disord; 2000; 11(6):299-313. PubMed ID: 11044775 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study. Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study. Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427 [TBL] [Abstract][Full Text] [Related]
9. Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease patients. Weiner MF; Martin-Cook K; Foster BM; Saine K; Fontaine CS; Svetlik DA J Clin Psychiatry; 2000 Jul; 61(7):487-92. PubMed ID: 10937606 [TBL] [Abstract][Full Text] [Related]
10. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression. Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. Feldman H; Gauthier S; Hecker J; Vellas B; Xu Y; Ieni JR; Schwam EM; Int J Geriatr Psychiatry; 2005 Jun; 20(6):559-69. PubMed ID: 15920715 [TBL] [Abstract][Full Text] [Related]
12. The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial. Raskind MA; Peskind ER; Truyen L; Kershaw P; Damaraju CV Arch Neurol; 2004 Feb; 61(2):252-6. PubMed ID: 14967774 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response. Sabbagh M; Cummings J; Christensen D; Doody R; Farlow M; Liu L; Mackell J; Fain R BMC Geriatr; 2013 Jun; 13():56. PubMed ID: 23742728 [TBL] [Abstract][Full Text] [Related]
14. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405 [TBL] [Abstract][Full Text] [Related]
15. Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: an exploratory study. Ishikawa K; Motoi Y; Mizuno Y; Kubo S; Hattori N Psychogeriatrics; 2014 Jun; 14(2):93-100. PubMed ID: 24661498 [TBL] [Abstract][Full Text] [Related]
16. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan. Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325 [TBL] [Abstract][Full Text] [Related]
17. Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine. Wang HC; Liu NY; Zhang S; Yang Y; Wang ZY; Wei Y; Liu JG; Pei H; Li H Chin J Integr Med; 2020 Mar; 26(3):212-218. PubMed ID: 32180150 [TBL] [Abstract][Full Text] [Related]
18. Medical interventions suppressed progression of advanced Alzheimer's disease more than mild Alzheimer's disease. Honjo Y; Ide K; Takechi H Geriatr Gerontol Int; 2020 Apr; 20(4):324-328. PubMed ID: 32037700 [TBL] [Abstract][Full Text] [Related]
19. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease? Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138 [TBL] [Abstract][Full Text] [Related]
20. Effects of donepezil on the amplitude of low-frequency fluctuations in the brain of patients with Alzheimer's disease: evidence from resting-state functional magnetic resonance imaging. Yang H; Zhang J; Cheng J Neuroreport; 2021 Aug; 32(11):907-912. PubMed ID: 34029287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]